| Autor: |
ELENA, P, VIAUD‐QUENTRIC, K, CHARFEDDINE, R, REKIK, R |
| Předmět: |
|
| Zdroj: |
Acta Ophthalmologica (1755375X); Sep2012 Supplement S249, Vol. 90, p0-0, 1p |
| Abstrakt: |
Purpose The aim of the present study was to evaluate the protective effects of eye drops the angiotensin‐converting enzyme (ACE) inhibitor ramipril on retinal ganglion cells (RGC) in a model of ischemia‐reperfusion (I/R) injury in pigmented rat retina. Methods Retinal I/R injury was induced in adult Long Evans rats by vascular ligation of the optic nerve for 45 minutes, after which reperfusion was immediately established. Rats were treated topically with Ramipril 2% or vehicle eyedrops three times before and after ischemia. Intraperitoneal injection of brimonidine (2 mg/kg) was used as reference. Post‐ischemic retinal function was assessed by scotopic electroretinography (ERG) and RGC density by immunofluorescence on retinal flatmounts 8 days after ischemia. Results In ischemic eyes, no ERG responses could be recorded immediately after reperfusion. They gradually recovered to approximately 75% of baseline 8 days after injury. Recoveries of the b‐wave in the Ramipril‐ and brimonidine groups were better than those in the vehicle group. Severe RGC loss was also observed after I/R injury. However, Ramipril and brimonidine treatments significantly enhanced RGC survival (270.43 ± 87.57 cells/mm2 and 300.65 ± 92.48 cells/mm2), in comparison with the vehicle group (178.42 ± 107.81 cells/mm2). Conclusion Multiple instillations of ramipril 2% enhanced rat RGC survival and retinal function in the ischemia‐reperfusion injury model. This warrants further evaluation of the neuroprotective properties of ramipril in eye diseases. Commercial interest [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text